Search research articles
Contact Us
Filters
Showing results (81-90 of 87) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 87 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 30, 2025
Utilization of Cancer Screening, Prevention, and Treatment in Women With Variants of Uncertain Significance in Breast Cancer Susceptibility Genes
Sarah M Nielsen, Emily M Russell, Rachel E Ellsworth, et al.
American Journal of Human Genetics
|
April 12, 2003
Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V
Anthony Antonellis, Rachel E Ellsworth, Nyamkhishig Sambuughin, et al.
JCO Global Oncology
|
June 6, 2024
Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics Study
Hikmat Abdel-Razeq, Baha' Sharaf, Hira Bani Hani, et al.
Frontiers in Digital Health
|
December 29, 2025
Empowering patients for biomarker-informed care: digital education to bridge HER2-low knowledge gaps in metastatic breast cancer
Heidi C Ko, Stuti Patel, Rachel E Ellsworth, et al.
The Journal of Urology
|
September 3, 2024
Reply by Authors
Neal Shore, Christopher Pieczonka, Sean Heron, et al.
Breast Cancer Research and Treatment
|
October 18, 2024
Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancer
Isaac Garcia-Murillas, Rosalind J Cutts, Giselle Walsh-Crestani, et al.
The Journal of Urology
|
August 9, 2024
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer
Neal Shore, Christopher Pieczonka, Sean Heron, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 87) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 87 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 30, 2025
Utilization of Cancer Screening, Prevention, and Treatment in Women With Variants of Uncertain Significance in Breast Cancer Susceptibility Genes
Sarah M Nielsen, Emily M Russell, Rachel E Ellsworth, et al.
American Journal of Human Genetics
|
April 12, 2003
Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V
Anthony Antonellis, Rachel E Ellsworth, Nyamkhishig Sambuughin, et al.
JCO Global Oncology
|
June 6, 2024
Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics Study
Hikmat Abdel-Razeq, Baha' Sharaf, Hira Bani Hani, et al.
Frontiers in Digital Health
|
December 29, 2025
Empowering patients for biomarker-informed care: digital education to bridge HER2-low knowledge gaps in metastatic breast cancer
Heidi C Ko, Stuti Patel, Rachel E Ellsworth, et al.
The Journal of Urology
|
September 3, 2024
Reply by Authors
Neal Shore, Christopher Pieczonka, Sean Heron, et al.
Breast Cancer Research and Treatment
|
October 18, 2024
Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancer
Isaac Garcia-Murillas, Rosalind J Cutts, Giselle Walsh-Crestani, et al.
The Journal of Urology
|
August 9, 2024
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer
Neal Shore, Christopher Pieczonka, Sean Heron, et al.
Page
of 9